HomeALPN • NASDAQ
Follow
Alpine Immune Sciences Inc
Previous close
$64.50
Day range
$64.42 - $64.50
Year range
$6.71 - $64.57
Market cap
4.23B USD
Avg Volume
3.08M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 30.85M | 1,011.42% |
Operating expense | 6.37M | 45.23% |
Net income | 5.96M | 131.59% |
Net profit margin | 19.32 | 102.84% |
Earnings per share | 0.15 | 136.59% |
EBITDA | 1.70M | 108.38% |
Effective tax rate | 1.70% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 327.41M | 37.78% |
Total assets | 379.85M | 32.50% |
Total liabilities | 51.91M | -51.61% |
Total equity | 327.94M | — |
Shares outstanding | 65.55M | — |
Price to book | 11.88 | — |
Return on assets | 1.25% | — |
Return on capital | 1.52% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 5.96M | 131.59% |
Cash from operations | -18.97M | -13.02% |
Cash from investing | -112.70M | -4.45% |
Cash from financing | 156.61M | 1,256.75% |
Net change in cash | 24.95M | 122.03% |
Free cash flow | -4.74M | 74.53% |
About
Founded
2007
Headquarters
Website
Employees
142